Sanofi Consumer Healthcare India Limited (SANOFICONR) Q1 2025 earnings summary

Executive summary

• Unaudited financial results for the quarter ended March 31, 2025, were approved by the Board on May 2, 2025.

• Results are not comparable year-over-year due to a voluntary product recall in the previous year.

Financial highlights

• Revenue from operations for Q1 2025 was ₹1,726 million, compared to ₹2,216 million in Q1 2024.

• Profit before tax for Q1 2025 was ₹668 million, down from ₹839 million in Q1 2024.

• Net profit for Q1 2025 stood at ₹500 million, compared to ₹627 million in Q1 2024.

• Basic and diluted EPS for Q1 2025 was ₹21.69, versus ₹27.22 in Q1 2024.

Outlook and guidance

• Depura Adult was relaunched during the quarter, with plans to bring back other recalled products soon.

• Minor returns from retailers related to the recall are expected in the coming months.